Sign up
Log in
RPT-BUZZ-PREVIEW: Travelers Cos shares rise ahead of results Wed
Share
Listen to the news
RPT-BUZZ-PREVIEW: Travelers Cos shares rise ahead of results Wed

Repeats item first published Tuesday with changes to text

** Shares of Travelers Cos TRV.N were up 0.8% in afternoon trading Tues ahead the insurer's quarterly results due before the bell Wed

** The co is expected to report an increase in quarterly rev to $10.509 bln from $9.396 bln a yr ago, while it is expected to report earnings of $4.90/shr vs $3.21 in the yr-ago period, according to LSEG data.

** The co has beaten analysts' earnings expectations in five of the past eight reporting periods, per LSEG

** Analyst recommendations on the stock include 10 "strong buy" or "buy" ratings, 14 "hold" ratings and three "sell" ratings, based on LSEG data

** The median 12-mo price target for TRV is $233.50; the stock was last at ​$222.94

** Earlier Tues both Citigroup and Raymond James raised their price targets on TRV

** TRV options imply a 4.1% swing for the shares, in either direction, by Fri; that is slightly higher than the stock's average reaction to earnings of 3.7%, over the last eight quarters, according to Trade Alert

** Including the session move, TRV's stock is up about 17% for the YTD, while the Dow Jones industrial average .DJI is up 0.2% for that period


(Reporting by Caroline Valetkevitch; additional reporting by Saqib Iqbal Ahmed in New York)

((caroline.valetkevitch@thomsonreuters.com))

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.